{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:56:07Z","timestamp":1784991367632,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The long-term effects of SARS-CoV-2 infection represent a relevant global health problem. Long COVID (LC) is defined as a complex of signs and symptoms developed during or after SARS-CoV-2 infection and lasting\u2009&gt;\u200912\u00a0weeks. In common variable immunodeficiency (CVID) patients, we previously reported higher risk of hospitalization and death during SARS-CoV-2 infection, as well as prolonged swab positivity and frequent reinfections. The aim of the present study was to assess the risk of LC in an Italian cohort of CVID patients. We used a translated version of the survey proposed by Centers for Disease Control and Prevention (CDC) to collect data on LC. In the enrolled cohort of 175 CVID patients, we found a high prevalence of LC (65.7%). The most frequent LC symptoms were fatigue (75.7%), arthralgia\/myalgia (48.7%), and dyspnea (41.7%). The majority of patients (60%) experienced prolonged symptoms, for at least 6\u00a0months after infection. In a multivariate analysis, the presence of complicated phenotype (OR 2.44, 95% CI 1.88\u20135.03; <jats:italic>p<\/jats:italic>\u2009=\u20090.015), obesity (OR 11.17, 95% CI 1.37\u201390.95; <jats:italic>p<\/jats:italic>\u2009=\u20090.024), and female sex (OR 2.06, 95% CI 1.09\u20133.89; <jats:italic>p<\/jats:italic>\u2009=\u20090.024) significantly correlated with the development of LC. In conclusion, in this multicenter observational cohort study, we demonstrated that CVID patients present an increased prevalence of LC when compared to the general population. Improved awareness on the risk of LC in CVID patients could optimize management of this new and alarming complication of SARS-CoV-2 infection.<\/jats:p>","DOI":"10.1007\/s10875-024-01656-2","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T12:02:32Z","timestamp":1707220952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study"],"prefix":"10.1007","volume":"44","author":[{"given":"Annalisa","family":"Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Milito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Maria","family":"Deiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Finco Gambier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Punziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Buso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Lagnese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Garzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Giannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pagnozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgil A. S. H.","family":"Dalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Spadaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Rattazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8486-5850","authenticated-orcid":false,"given":"Francesco","family":"Cinetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Firinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"1656_CR1","unstructured":"Coronavirus disease (COVID-19) situation reports [Internet]. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports.\u00a0Accessed 22 Dec 2023."},{"key":"1656_CR2","doi-asserted-by":"publisher","first-page":"03067","DOI":"10.7189\/jogh.12.03067","volume":"12","author":"MA Faghy","year":"2022","unstructured":"Faghy MA, Owen R, Thomas C, Yates J, Ferraro FV, Skipper L, et al. Is long COVID the next global health crisis? J Glob Health. 2022;12:03067. https:\/\/doi.org\/10.7189\/jogh.12.03067.","journal-title":"J Glob Health"},{"key":"1656_CR3","doi-asserted-by":"publisher","unstructured":"Ruiz-Pablos M, Paiva B, Montero-Mateo R, Garcia N, Zabaleta A. Epstein-Barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.656797.","DOI":"10.3389\/fimmu.2021.656797"},{"key":"1656_CR4","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/cid\/ciu629","volume":"59","author":"K Hanevik","year":"2014","unstructured":"Hanevik K, Wensaas K-A, Rortveit G, Eide GE, M\u00f8rch K, Langeland N. Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;59:1394\u2013400. https:\/\/doi.org\/10.1093\/cid\/ciu629.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"1656_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/jnsm.jnsm_133_22","volume":"6","author":"M Masood","year":"2023","unstructured":"Masood M, Chodisetti S, BaHammam A. Long COVID: the long-term consequences of COVID-19 and the proposed pathophysiological mechanisms. J Nat Sci Med. 2023;6(1):3\u201311. https:\/\/doi.org\/10.4103\/jnsm.jnsm_133_22.","journal-title":"J Nat Sci Med"},{"key":"1656_CR6","unstructured":"Post COVID-19 condition [Internet]. Available from: https:\/\/www.who.int\/teams\/health-care-readiness\/post-covid-19-condition.\u00a0Accessed 22 Dec 2023."},{"key":"1656_CR7","unstructured":"Post COVID-19 condition (long COVID) [Internet]. Available from: https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition.\u00a0Accessed 22 Dec 2023"},{"key":"1656_CR8","doi-asserted-by":"crossref","unstructured":"Ford ND. Long COVID and significant activity limitation among adults, by age \u2014 United States, June 1\u201313, 2022, to June 7\u201319, 2023. MMWR Morb Mortal Wkly Rep [Internet]. 2023;72. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/72\/wr\/mm7232a3.htm.\u00a0Accessed 22 Dec 2023","DOI":"10.15585\/mmwr.mm7232a3"},{"key":"1656_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1017\/neu.2022.13","volume":"34","author":"HY Alghamdi","year":"2022","unstructured":"Alghamdi HY, Alrashed AM, Jawhari AM, Abdel-Moneim AS. Neuropsychiatric symptoms in post-COVID-19 long haulers. Acta Neuropsychiatr. 2022;34:318\u201329. https:\/\/doi.org\/10.1017\/neu.2022.13.","journal-title":"Acta Neuropsychiatr"},{"key":"1656_CR10","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","volume":"28","author":"A Subramanian","year":"2022","unstructured":"Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706\u201314. https:\/\/doi.org\/10.1038\/s41591-022-01909-w.","journal-title":"Nat Med"},{"key":"1656_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jmv.27309","volume":"94","author":"P Malik","year":"2022","unstructured":"Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-a systematic review and meta-analysis. J Med Virol. 2022;94:253\u201362. https:\/\/doi.org\/10.1002\/jmv.27309.","journal-title":"J Med Virol"},{"key":"1656_CR12","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","volume":"226","author":"C Chen","year":"2022","unstructured":"Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226:1593\u2013607. https:\/\/doi.org\/10.1093\/infdis\/jiac136.","journal-title":"J Infect Dis"},{"key":"1656_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28862","volume":"95","author":"J Luo","year":"2023","unstructured":"Luo J, Zhang J, Tang HT, Wong HK, Lyu A, Cheung CH, et al. Prevalence and risk factors of long COVID 6\u201312 months after infection with the Omicron variant among nonhospitalized patients in Hong Kong. J Med Virol. 2023;95: e28862. https:\/\/doi.org\/10.1002\/jmv.28862.","journal-title":"J Med Virol"},{"key":"1656_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijid.2022.12.036","volume":"128","author":"W Jassat","year":"2023","unstructured":"Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102\u201311. https:\/\/doi.org\/10.1016\/j.ijid.2022.12.036.","journal-title":"Int J Infect Dis"},{"key":"1656_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1098","volume":"373","author":"SE Daugherty","year":"2021","unstructured":"Daugherty SE, Guo Y, Heath K, Dasmari\u00f1as MC, Jubilo KG, Samranvedhya J, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373: n1098. https:\/\/doi.org\/10.1136\/bmj.n1098.","journal-title":"BMJ"},{"key":"1656_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijid.2022.01.007","volume":"116","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2022","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Pellicer-Valero OJ, Navarro-Pardo E, Palacios-Ce\u00f1a D, Florencio LL, Guijarro C, et al. Symptoms experienced at the acute phase of SARS-CoV-2 infection as risk factor of long-term post-COVID symptoms: the LONG-COVID-EXP-CM multicenter study. Int J Infect Dis. 2022;116:241\u20134. https:\/\/doi.org\/10.1016\/j.ijid.2022.01.007.","journal-title":"Int J Infect Dis"},{"key":"1656_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40520-021-02042-3","volume":"34","author":"V Cristillo","year":"2022","unstructured":"Cristillo V, Pilotto A, Cotti Piccinelli S, Bonzi G, Canale A, Gipponi S, et al. Premorbid vulnerability and disease severity impact on long-COVID cognitive impairment. Aging Clin Exp Res. 2022;34:257\u201360. https:\/\/doi.org\/10.1007\/s40520-021-02042-3.","journal-title":"Aging Clin Exp Res"},{"key":"1656_CR18","doi-asserted-by":"publisher","first-page":"12422","DOI":"10.3390\/ijerph191912422","volume":"19","author":"P Gao","year":"2022","unstructured":"Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19:12422. https:\/\/doi.org\/10.3390\/ijerph191912422.","journal-title":"Int J Environ Res Public Health"},{"key":"1656_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.920627","volume":"13","author":"J Garc\u00eda-Abell\u00e1n","year":"2022","unstructured":"Garc\u00eda-Abell\u00e1n J, Fern\u00e1ndez M, Padilla S, Garc\u00eda JA, Agull\u00f3 V, Lozano V, et al. Immunologic phenotype of patients with long-COVID syndrome of 1-year duration. Front Immunol. 2022;13: 920627. https:\/\/doi.org\/10.3389\/fimmu.2022.920627.","journal-title":"Front Immunol"},{"key":"1656_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41467-021-27797-1","volume":"13","author":"C Cervia","year":"2022","unstructured":"Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13:446. https:\/\/doi.org\/10.1038\/s41467-021-27797-1.","journal-title":"Nat Commun"},{"key":"1656_CR21","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","volume":"7","author":"MG Seidel","year":"2019","unstructured":"Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7:1763\u201370. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.004.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1656_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jaci.2022.11.010","volume":"151","author":"SG Tangye","year":"2023","unstructured":"Tangye SG, COVID Human Genetic Effort consortium. Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity. J Allergy Clin Immunol. 2023;151:818\u201331. https:\/\/doi.org\/10.1016\/j.jaci.2022.11.010.","journal-title":"J Allergy Clin Immunol."},{"key":"1656_CR23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10875-022-01264-y","volume":"42","author":"G Giardino","year":"2022","unstructured":"Giardino G, Milito C, Lougaris V, Punziano A, Carrabba M, Cinetto F, et al. The impact of SARS-CoV-2 infection in patients with inborn errors of immunity: the experience of the Italian Primary Immunodeficiencies Network (IPINet). J Clin Immunol. 2022;42:935\u201346. https:\/\/doi.org\/10.1007\/s10875-022-01264-y.","journal-title":"J Clin Immunol"},{"key":"1656_CR24","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","volume":"147","author":"AM Shields","year":"2021","unstructured":"Shields AM, Burns SO, Savic S, Richter AG, UK PIN COVID-19 Consortium. COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147:870-875.e1. https:\/\/doi.org\/10.1016\/j.jaci.2020.12.620.","journal-title":"J Allergy Clin Immunol"},{"key":"1656_CR25","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","volume":"42","author":"A Bousfiha","year":"2022","unstructured":"Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42:1508\u201320. https:\/\/doi.org\/10.1007\/s10875-022-01352-z.","journal-title":"J Clin Immunol"},{"key":"1656_CR26","doi-asserted-by":"publisher","first-page":"1093385","DOI":"10.3389\/fimmu.2023.1093385","volume":"14","author":"C Milito","year":"2023","unstructured":"Milito C, Firinu D, Bez P, Villa A, Punziano A, Lagnese G, et al. A beacon in the dark: COVID-19 course in CVID patients from two European countries: different approaches, similar outcomes. Front Immunol. 2023;14:1093385. https:\/\/doi.org\/10.3389\/fimmu.2023.1093385.","journal-title":"Front Immunol"},{"key":"1656_CR27","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1016\/j.jaip.2021.04.017","volume":"9","author":"C Milito","year":"2021","unstructured":"Milito C, Lougaris V, Giardino G, Punziano A, Vultaggio A, Carrabba M, et al. Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity. J Allergy Clin Immunol Pract. 2021;9:2904-2906.e2. https:\/\/doi.org\/10.1016\/j.jaip.2021.04.017.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1656_CR28","unstructured":"ESID - European Society for Immunodeficiencies [Internet]. Available from: https:\/\/esid.org\/Working-Parties\/Registry-Working-Party\/.\u00a0Accessed 22 Dec 2023"},{"key":"1656_CR29","unstructured":"Sanit\u00e0 E-IS di. EpiCentro [Internet]. Available from: https:\/\/www.epicentro.iss.it\/.\u00a0Accessed 22 Dec 2023"},{"key":"1656_CR30","doi-asserted-by":"publisher","unstructured":"Bergna A, Lai A, Ventura CD, et al. Genomic epidemiology of the main SARS-CoV-2 variants circulating in Italy in 2020 and 2022 period. Authorea Preprints; 2023. https:\/\/doi.org\/10.22541\/au.168931270.03874429\/v1.","DOI":"10.22541\/au.168931270.03874429\/v1"},{"key":"1656_CR31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.jaci.2012.05.046","volume":"130","author":"H Chapel","year":"2012","unstructured":"Chapel H, Lucas M, Patel S, Lee M, Cunningham-Rundles C, Resnick E, et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol. 2012;130:1197-1198.e9. https:\/\/doi.org\/10.1016\/j.jaci.2012.05.046.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1656_CR32","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection","year":"2020","unstructured":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192\u20137. https:\/\/doi.org\/10.1016\/S1473-3099(20)30483-7.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1656_CR33","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102\u20137. https:\/\/doi.org\/10.1016\/S1473-3099(21)00703-9.","journal-title":"Lancet Infect Dis"},{"key":"1656_CR34","unstructured":"Long COVID - household pulse survey - COVID-19 [Internet]. Available from: https:\/\/www.cdc.gov\/nchs\/covid19\/pulse\/long-covid.htm.\u00a0Accessed 22 Dec 2023"},{"key":"1656_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.18176\/jiaci.0388","volume":"30","author":"R Yazdani","year":"2020","unstructured":"Yazdani R, Habibi S, Sharifi L, Azizi G, Abolhassani H, Olbrich P, et al. Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management. J Investig Allergol Clin Immunol. 2020;30:14\u201334. https:\/\/doi.org\/10.18176\/jiaci.0388.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"5","key":"1656_CR36","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.anai.2022.06.009","volume":"129","author":"JR Durkee-Shock","year":"2022","unstructured":"Durkee-Shock JR, Keller MD. Immunizing the imperfect immune system: coronavirus disease 2019 vaccination in patients with inborn errors of immunity. Ann Allergy Asthma Immunol. 2022;129(5):562-571.e1. https:\/\/doi.org\/10.1016\/j.anai.2022.06.009.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1656_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12985-023-02061-8","volume":"20","author":"C Wang","year":"2023","unstructured":"Wang C, Ramasamy A, Verduzco-Gutierrez M, Brode WM, Melamed E. Acute and post-acute sequelae of SARS-CoV-2 infection: a review of risk factors and social determinants. Virol J. 2023;20:124. https:\/\/doi.org\/10.1186\/s12985-023-02061-8.","journal-title":"Virol J"},{"key":"1656_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210\u20136. https:\/\/doi.org\/10.1038\/s41590-021-01113-x.","journal-title":"Nat Immunol"},{"key":"1656_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10875-016-0367-1","volume":"37","author":"J Hajjar","year":"2017","unstructured":"Hajjar J, Guffey D, Minard CG, Orange JS. Increased incidence of fatigue in patients with primary immunodeficiency disorders: prevalence and associations within the US Immunodeficiency Network Registry. J Clin Immunol. 2017;37:153\u201365. https:\/\/doi.org\/10.1007\/s10875-016-0367-1.","journal-title":"J Clin Immunol"},{"issue":"11","key":"1656_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29246","volume":"95","author":"JY Wu","year":"2023","unstructured":"Wu JY, Liu MY, Hung KC, Hsu WH, Tsai YW, Liu TH, et al. Nutritional deficiency anemia and post-acute sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: a six-month retrospective cohort analysis of 30 892 patients. J Med Virol. 2023;95(11): e29246. https:\/\/doi.org\/10.1002\/jmv.29246.","journal-title":"J Med Virol"},{"key":"1656_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clim.2016.07.001","volume":"169","author":"C de Lollo","year":"2016","unstructured":"de Lollo C, de MoraesVasconcelos D, da Silva Oliveira LM, Domingues R, de Carvalho GC, da Silva Duarte AJ, et al. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency. Clin Immunol Orlando Fla. 2016;169:121\u20137. https:\/\/doi.org\/10.1016\/j.clim.2016.07.001.","journal-title":"Clin Immunol Orlando Fla"},{"key":"1656_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.645013","volume":"12","author":"K-T Tang","year":"2021","unstructured":"Tang K-T, Hsu B-C, Chen D-Y. Autoimmune and rheumatic manifestations associated with COVID-19 in adults: an updated systematic review. Front Immunol. 2021;12: 645013. https:\/\/doi.org\/10.3389\/fimmu.2021.645013.","journal-title":"Front Immunol"},{"key":"1656_CR43","doi-asserted-by":"publisher","first-page":"rkac008","DOI":"10.1093\/rap\/rkac008","volume":"6","author":"L Leon","year":"2022","unstructured":"Leon L, Perez-Sancristobal I, Madrid A, Lopez-Pedraza L, Colomer JI, Lerma S, et al. Persistent post-discharge symptoms after COVID-19 in rheumatic and musculoskeletal diseases. Rheumatol Adv Pract. 2022;6:rkac008. https:\/\/doi.org\/10.1093\/rap\/rkac008.","journal-title":"Rheumatol Adv Pract"},{"key":"1656_CR44","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1016\/S2665-9913(23)00127-3","volume":"5","author":"L Boekel","year":"2023","unstructured":"Boekel L, Atiqi S, Leeuw M, Hooijberg F, Besten YR, Wartena R, et al. Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands. Lancet Rheumatol. 2023;5:e375\u201385. https:\/\/doi.org\/10.1016\/S2665-9913(23)00127-3.","journal-title":"Lancet Rheumatol"},{"key":"1656_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2021.02.029","volume":"137","author":"SH Ahn","year":"2021","unstructured":"Ahn SH, Kim JL, Kim JR, Lee SH, Yim HW, Jeong H, et al. Association between chronic fatigue syndrome and suicidality among survivors of Middle East respiratory syndrome over a 2-year follow-up period. J Psychiatr Res. 2021;137:1\u20136. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.02.029.","journal-title":"J Psychiatr Res"},{"issue":"9","key":"1656_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.703853","volume":"27","author":"B Rivalta","year":"2021","unstructured":"Rivalta B, Amodio D, Milito C, Chiriaco M, Di Cesare S, Giancotta C, et al. Case report: ebv chronic infection and lymphoproliferation in four APDS patients: the challenge of proper characterization, therapy, and follow-up. Front Pediatr. 2021;27(9): 703853. https:\/\/doi.org\/10.3389\/fped.2021.703853.","journal-title":"Front Pediatr"},{"issue":"1","key":"1656_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10875-022-01368-5","volume":"43","author":"V Allain","year":"2023","unstructured":"Allain V, Grandin V, Meignin V, Bertinchamp R, Boutboul D, Fieschi C, Galicier L, et al. Lymphoma as an exclusion criteria for CVID diagnosis revisited. J Clin Immunol. 2023;43(1):181\u201391. https:\/\/doi.org\/10.1007\/s10875-022-01368-5.","journal-title":"J Clin Immunol"},{"key":"1656_CR48","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jaip.2020.10.028","volume":"9","author":"C von Spee-Mayer","year":"2021","unstructured":"von Spee-Mayer C, Echternach C, Agarwal P, Gutenberger S, Soetedjo V, Goldacker S, et al. Abatacept use is associated with steroid dose reduction and improvement in fatigue and CD4-dysregulation in CVID patients with interstitial lung disease. J Allergy Clin Immunol Pract. 2021;9:760-770.e10. https:\/\/doi.org\/10.1016\/j.jaip.2020.10.028.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"1656_CR49","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.jaip.2020.04.003","volume":"8","author":"F Pulvirenti","year":"2020","unstructured":"Pulvirenti F, Cinetto F, Milito C, Bonanni L, Pesce AM, Leodori G, et al. Health-related quality of life in common variable immunodeficiency Italian patients switched to remote assistance during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8(6):1894-1899.e2. https:\/\/doi.org\/10.1016\/j.jaip.2020.04.003.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1656_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12016-021-08848-3","volume":"64","author":"B Oronsky","year":"2023","unstructured":"Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol. 2023;64:66\u201374. https:\/\/doi.org\/10.1007\/s12016-021-08848-3.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1656_CR51","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.3390\/ijerph19095185","volume":"19","author":"S Fugazzaro","year":"2022","unstructured":"Fugazzaro S, Contri A, Esseroukh O, Kaleci S, Croci S, Massari M, et al. Rehabilitation interventions for post-acute COVID-19 syndrome: a systematic review. Int J Environ Res Public Health. 2022;19:5185. https:\/\/doi.org\/10.3390\/ijerph19095185.","journal-title":"Int J Environ Res Public Health"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01656-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01656-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01656-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T09:28:29Z","timestamp":1730366909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01656-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1656"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01656-2","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"14 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper was updated due to incorrect structuring of the given and family names of Renato Finco Gambier","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Ethical Committee of the Sapienza University of Rome (CE 5834, n.052\/2020 and CE 4604, n.316\/2016).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was waived by the Institutional Review Board due to the observational nature of the study and anonymization before analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"59"}}